Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

AVTX

Avalo Therapeutics Inc

May 07 • 04:00PM ET

22.87

+1.06 4.86 %

Healthcare • Biotechnology • USA • Small • NASD

Peers: ZURA COGT AUPH KYTX ARQT

| Held by: VTI VXF ITOT IWC TMSL DFAS TMED DFMC BMED DXUV

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-6.10	Insider Own	10.04%	Shs Outstand	26.71M	Perf Week	70.67%
Market Cap	610.96M	Forward P/E	-	EPS next Y	-4.03	Insider Trans	-10.30%	Shs Float	24.03M	Perf Month	58.71%
Enterprise Value	515.02M	PEG	-	EPS next Q	-1.03	Inst Own	72.01%	Short Float	21.80%	Perf Quarter	73.92%
Income	-78.26M	P/S	10182.67	EPS this Y	39.48%	Inst Trans	44.67%	Short Ratio	4.33	Perf Half Y	42.14%
Sales	0.06M	P/B	5.10	EPS next Y	-14.08%	ROA	-58.31%	Short Interest	5.24M	Perf YTD	25.94%
Book/sh	4.49	P/C	6.21	EPS next 5Y	14.19%	ROE	-72.43%	52W High	23.71 -3.54%	Perf Year	413.93%
Cash/sh	3.68	P/FCF	-	EPS past 3/5Y	82.35% 70.20%	ROIC	-91.98%	52W Low	3.39 574.63%	Perf 3Y	-96.33%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	-85.16% -61.19%	Gross Margin	-483.05%	Volatility	15.69% 9.85%	Perf 5Y	-99.71%
Dividend TTM	-	EV/Sales	8583.67	EPS Y/Y TTM	95.62%	Oper. Margin	-123601.69%	ATR (14)	1.79	Perf 10Y	-99.79%
Dividend Ex-Date	-	Quick Ratio	8.14	Sales Y/Y TTM	-86.62%	Profit Margin	-132642.37%	RSI (14)	78.16	Recom	1.00
Dividend Gr. 3/5Y	- -	Current Ratio	8.14	EPS Q/Q	78.04%	SMA20	53.73%	Beta	0.83	Target Price	46.90
Payout	-	Debt/Eq	0.03	Sales Q/Q	-69.27%	SMA50	47.89%	Rel Volume	5.04	Prev Close	21.81
Employees	33	LT Debt/Eq	0.02	Earnings	Mar 23 BMO	SMA200	57.80%	Avg Volume	1.21M	Price	22.87
IPO	Nov 13, 2015	Option/Short	Yes / Yes	EPS/Sales Surpr.	47.48% -	Trades		Volume	5,742,151	Change	4.86%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)